Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Overview of attention for article published in Cancer Immunology, Immunotherapy, September 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 23 X posts from 19 X users, with an upper bound of 63,639 followers.

RT @fsabino_onco: Just out one more piece of the ARON project. Now evaluating the concomitant use of medications with ICI and the outcomes…

RT @nataliagandur: 💫🌟Truly honored to be part of this amazing team!!! 🌟💫 👏👏👏Congratulations to all the authors on this groundbreaking work…

RT @fsabino_onco: Just out one more piece of the ARON project. Now evaluating the concomitant use of medications with ICI and the outcomes…

RT @nataliagandur: 💫🌟Truly honored to be part of this amazing team!!! 🌟💫 👏👏👏Congratulations to all the authors on this groundbreaking work…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.